What is the contribution of molecular studies to the diagnosis of BCR-ABL-positive disease in adult acute leukemia?
The detection of BCR-ABL transcripts by polymerase chain reaction and hybridization protection assay was investigated in 59 adults with acute leukemia in whom the Philadelphia chromosome (Ph) abnormality was not documented by cytogenetic analysis. These included 35 patients with acute lymphocytic leukemia (ALL) and 24 with acute myelogenous leukemia (AML). Overall, three patients were found to have Ph-related molecular abnormalities; one had p190 and two had p210 disease. All three patients had ALL and were among 16 patients with insufficient metaphases by cytogenetic analysis, yielding an incidence of 19% in the latter category. Based on a 32% incidence of insufficient metaphases in our adult ALL population, we project an additional detection rate of 6% Ph-positive ALL by molecular studies and an overall incidence of 20% (14% + 6%) Ph-positive or BCR-ABL-positive ALL. None of the remaining patients with ALL and none of the 24 patients with AML investigated had BCR-ABL-positive disease. We conclude that molecular studies are useful in detecting BCR-ABL-positive disease in a subset of patients with Ph-positive ALL who are not identified by cytogenetic analysis because of insufficient metaphases.
Kantarjian
H
H
Department of Hematology, Anderson Cancer Center, Houston, Texas 77030.
Talpaz
M
M
Estey
E
E
Ku
S
S
Kurzrock
R
R
D000208:Acute Disease; D000328:Adult; D000368:Aged; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000032:analysis*; D015870:Gene Expression; D016313:Genes, abl; D006801:Humans; D017403:In Situ Hybridization / Q000379:methods; D007621:Karyotyping; D007951:Leukemia, Myeloid / Q000145:classification / Q000175:diagnosis / Q000235:genetics*; D008163:Luminescent Measurements; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000145:classification / Q000175:diagnosis / Q000235:genetics*
D016044:Fusion Proteins, bcr-abl